- Home
- LILAK vs RXRX Comparison
LILAK vs RXRX Comparison
Compare LILAK & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LILAK | RXRX |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | Bermuda | United States |
| Employees | 9000 | N/A |
| Industry | Cable & Other Pay Television Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.9B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | LILAK | RXRX |
|---|---|---|
| Price | $7.50 | $3.80 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $8.20 | $7.50 |
| AVG Volume (30 Days) | 814.8K | ★ 15.9M |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $74,681,000.00 |
| Revenue This Year | $1.37 | $12.11 |
| Revenue Next Year | N/A | $82.52 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 26.92 |
| 52 Week Low | $5.04 | $2.77 |
| 52 Week High | $9.13 | $7.18 |
Technical Indicators
Market Signals| Indicator | LILAK | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 43.22 | 62.58 |
| Support Level | $7.54 | $2.85 |
| Resistance Level | $8.42 | $3.99 |
| Average True Range (ATR) | 0.36 | 0.27 |
| MACD | 0.01 | 0.09 |
| Stochastic Oscillator | 39.74 | 82.28 |
Price Performance
Historical ComparisonAbout LILAK Liberty Latin America Ltd. Class C
Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.